0 Évaluations

ID

25336

Description

Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome

Mots-clés

  1. 2017-09-01 2017-09-01 -
  2. 2017-09-01 2017-09-01 -
Téléchargé le

1 september 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 12 Day (Form 16)

    GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 12 Day (Form 16)

    General Information
    Description

    General Information

    Center Number
    Description

    Center Number

    Type de données

    integer

    Patient Number
    Description

    Patient Number

    Type de données

    integer

    Patient Initials
    Description

    Patient Initials

    Type de données

    text

    Visit Date
    Description

    Visit Date

    Type de données

    date

    Investigational Product Record since last visit
    Description

    Investigational Product Record since last visit

    Please complete the investigational product record in the Investigational Product and Compliance Section at the back of this book. Please complete the Investigational Product Interruption record in the Investigational Product and Compliance Section at the back of this book.
    Description

    Investigational Product Record since last visit

    Type de données

    boolean

    RSL Rating Scale
    Description

    RSL Rating Scale

    INVESTIGATOR: Please complete the appropriate RLS Rating Scale from the RLS Rating Scale Book.
    Description

    RSL Rating Scale

    Type de données

    boolean

    Vital Signs
    Description

    Vital Signs

    Weight (without shoes)
    Description

    Weight

    Type de données

    float

    Unités de mesure
    • kg/lbs
    kg/lbs
    Pulse (after 5 minutes sitting)
    Description

    Pulse

    Type de données

    integer

    Unités de mesure
    • beats/min
    beats/min
    Sitting Blood Pressure (after 5 minutes sitting) systolic
    Description

    Sitting Blood Pressure systolic

    Type de données

    integer

    Unités de mesure
    • mmHg
    mmHg
    Sitting Blood pressure (after 5 minutes sitting) diastolic
    Description

    Sitting Blood pressure diastolic

    Type de données

    integer

    Unités de mesure
    • mmHg
    mmHg
    Please record any medical procedures performed since the last visit in the Medical Procedures section at the back of this book.
    Description

    Medical Procedures

    Type de données

    boolean

    Please record any changes in concomitant medication since the last visit in the Concomitant Medication section at the back of this book.
    Description

    Concomitant Medication

    Type de données

    boolean

    Please record any adverse experiences observed or elicited by the following direct question to the patient: "Have you felt different in any way since the Week 8 Visit?" in the Adverse Experience section at the back of this book.
    Description

    Adverse Experiences

    Type de données

    boolean

    Laboratory Evaluation
    Description

    Laboratory Evaluation

    Date of blood sample
    Description

    Date of blood sample

    Type de données

    date

    Were any clinically significant abnormalities detected?
    Description

    Results

    Type de données

    text

    Similar models

    GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 12 Day (Form 16)

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    General Information
    Center Number
    Item
    Center Number
    integer
    Patient Number
    Item
    Patient Number
    integer
    Patient Initials
    Item
    Patient Initials
    text
    Visit Date
    Item
    Visit Date
    date
    Item Group
    Investigational Product Record since last visit
    Investigational Product Record since last visit
    Item
    Please complete the investigational product record in the Investigational Product and Compliance Section at the back of this book. Please complete the Investigational Product Interruption record in the Investigational Product and Compliance Section at the back of this book.
    boolean
    Item Group
    RSL Rating Scale
    RSL Rating Scale
    Item
    INVESTIGATOR: Please complete the appropriate RLS Rating Scale from the RLS Rating Scale Book.
    boolean
    Item Group
    Vital Signs
    Weight
    Item
    Weight (without shoes)
    float
    Pulse
    Item
    Pulse (after 5 minutes sitting)
    integer
    Sitting Blood Pressure systolic
    Item
    Sitting Blood Pressure (after 5 minutes sitting) systolic
    integer
    Sitting Blood pressure diastolic
    Item
    Sitting Blood pressure (after 5 minutes sitting) diastolic
    integer
    Medical Procedures
    Item
    Please record any medical procedures performed since the last visit in the Medical Procedures section at the back of this book.
    boolean
    Concomitant Medication
    Item
    Please record any changes in concomitant medication since the last visit in the Concomitant Medication section at the back of this book.
    boolean
    Adverse Experiences
    Item
    Please record any adverse experiences observed or elicited by the following direct question to the patient: "Have you felt different in any way since the Week 8 Visit?" in the Adverse Experience section at the back of this book.
    boolean
    Item Group
    Laboratory Evaluation
    Date of blood sample
    Item
    Date of blood sample
    date
    Item
    Were any clinically significant abnormalities detected?
    text
    Code List
    Were any clinically significant abnormalities detected?
    CL Item
    No (1)
    CL Item
    Yes -> If "Positive", please record details in the Pregnancy Information section on the Study Conclusion page at the back of this book. (2)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial